Published in Health Business Week, August 14th, 2009
Net income from continuing operations attributable to NovaMed in the second quarter of 2009 increased 17% to $2,122,000, or $0.09 per diluted share, from $1,806,000, or $0.07 per diluted share, in the prior year second quarter. Interest...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.